Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real‐world cohort analysis
Gundolf Schuettfort(Goethe University Frankfurt), Annette E. Haberl(Goethe University Frankfurt), Roser Navarro‐Soler(Hospital Universitario 12 De Octubre), Alfonso Cabello(Hospital Universitario Fundación Jiménez Díaz), Rafael Micán(Hospital Universitario La Paz), Christoph Stephan(Goethe University Frankfurt), Sebastian Noé, Rosário Serrão(Hospital de São João), Jordi Puig(Universitat Autònoma de Barcelona), Jürgen K. Rockstroh(University of Bonn), Carmen Hidalgo‐Tenorio(Hospital Universitario Virgen de las Nieves), Eva Herrmann(Goethe University Frankfurt), Sergio Rodrı́guez(Hospital Universitario de Getafe), María José Crusells(Hospital Clínico Universitario Lozano Blesa), Miguel Torralba(Universidad de Alcalá), Juan Carlos López, Miguel Górgolas(Hospital Universitario Fundación Jiménez Díaz), Diva Trigo(Hospital Prof. Dr. Fernando Fonseca), Federico Pulido(Bellvitge University Hospital), Jan Borch(Praxis), Eugènia Negredo(Universitat de Vic - Universitat Central de Catalunya)
Cited by 1
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
A European aerosol phenomenology—2: chemical characteristics of particulate matter at kerbside, urban, rural and background sites in Europe
|Atmospheric Environment|2004|892
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423
Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2005|385